Publication:
Abo and rh blood groups and risk of myelomeningocele

dc.contributor.coauthorIsik, Semra
dc.contributor.coauthorCevik, Serdar
dc.contributor.coauthorTurhan, Ali Haydar
dc.contributor.coauthorHanimoglu, Hakan
dc.contributor.departmentN/A
dc.contributor.kuauthorBaygül, Arzu Eden
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid272290
dc.date.accessioned2024-11-09T22:45:37Z
dc.date.issued2020
dc.description.abstractAIM: To investigate the relationship between the distribution of ABO or Rhesus (Rh) blood group antigens and the incidence of myelomeningocele. MATERIAL and METHODS: A retrospective data was reviewed for all myelomeningocele patients operated at a tertiary academic hospital between years 2014 and 2019. Age, sex, delivery method, physical and neurological examination findings, and radiological findings alongside with blood type of each patient were recorded. The data of blood group distribution among the study patients was compared to the data of healthy individuals in the same region. RESULTS: Patients with group B and AB showed a higher chance of developing myelomeningocele. Rh-positive blood group was associated with high incidence of myelomeningocele (93.5%), whereas Rh-negative blood group showed least association (6.5%). Rh-positive blood group was also found to be more frequent in patients with myelomeningocele with hydrocephalus and Chiari malformation. CONCLUSION: The findings of this study show that ABO and Rh blood groups have an effect on the development of myelomeningocele under the influence of environmental or genetic factors.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyTR Dizin
dc.description.issue3
dc.description.openaccessYES
dc.description.publisherscopeNational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume30
dc.identifier.doi10.5137/1019-5149.JTN.28913-19.2
dc.identifier.issn1019-5149
dc.identifier.quartileQ4
dc.identifier.scopus2-s2.0-85085265662
dc.identifier.urihttp://dx.doi.org/10.5137/1019-5149.JTN.28913-19.2
dc.identifier.urihttps://hdl.handle.net/20.500.14288/6130
dc.identifier.wos535739800018
dc.keywordsAbo blood groups
dc.keywordsMyelomeningocele
dc.keywordsNeural tube defects
dc.keywordsRh blood groups neural-tube defects
dc.keywordsOne-carbon metabolism
dc.keywordsGenetic-variation
dc.keywordsGroup antigens
dc.keywordsAssociation
dc.keywordsFolate
dc.keywordsCancer
dc.keywordsPolymorphisms
dc.keywordsReductase
dc.keywordsSystem
dc.languageEnglish
dc.publisherTurkish Neurosurgical Soc
dc.sourceTurkish Neurosurgery
dc.subjectClinical neurology
dc.subjectSurgery
dc.titleAbo and rh blood groups and risk of myelomeningocele
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0003-0392-6709
local.contributor.kuauthorBaygül, Arzu Eden

Files